10x Genomics CEO Disposes of $367,096 in Stock as Shares Hover Near Yearly High
10x Genomics Chief Executive Officer Serge Saxonov sold 16,152 shares of Class A common stock on March 2, 2026, in two tranches that generated roughly $367,096 in proceeds. The transactions occurred as the stock traded close to a 52-week peak and following the company’s fourth-quarter 2025 earnings beat and subsequent analyst price-target increases…